Skip to main content

2 Result(s)

within Taihang Shao Remove this filter Biomedicine Remove this filter

and

  1. Article

    Open Access

    Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis

    To compare the efficacy, safety and effects on quality of life of different ALK-inhibitors for global and Asian patients with advanced ALK-positive non-small-cell lung cancer (NSCLC).

    Mingye Zhao, Taihang Shao, Hanqiao Shao, Caicun Zhou, Wenxi Tang in BMC Cancer (2024)

    Download PDF (3888 KB) View Article

  2. No Access

    Article

    Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing

    Serplulimab is a potential valuable therapy, while patients, physicians, and decision-makers are uncertain about the cost-effectiveness of this novel drug and its corresponding reasonable price. This study aim...

    Taihang Shao, Mingye Zhao, Leyi Liang, Wenxi Tang in BioDrugs (2023)